Legend Biotech (LEGN) Net Cash Flow: 2019-2025
Historic Net Cash Flow for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to $31.0 million.
- Legend Biotech's Net Cash Flow fell 88.72% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$186.8 million, marking a year-over-year increase of 63.07%. This contributed to the annual value of -$1.0 billion for FY2024, which is 329.96% down from last year.
- Per Legend Biotech's latest filing, its Net Cash Flow stood at $31.0 million for Q3 2025, which was up 115.43% from -$201.1 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Net Cash Flow ranged from a high of $558.5 million in Q2 2023 and a low of -$714.0 million during Q2 2024.
- In the last 3 years, Legend Biotech's Net Cash Flow had a median value of -$127.4 million in 2023 and averaged -$46.8 million.
- Per our database at Business Quant, Legend Biotech's Net Cash Flow tumbled by 611.55% in 2022 and then soared by 19,469.83% in 2023.
- Legend Biotech's Net Cash Flow (Quarterly) stood at $350.5 million in 2021, then crashed by 107.30% to -$25.6 million in 2022, then spiked by 1,322.17% to $312.8 million in 2023, then plummeted by 154.43% to -$170.3 million in 2024, then tumbled by 88.72% to $31.0 million in 2025.
- Its Net Cash Flow stands at $31.0 million for Q3 2025, versus -$201.1 million for Q2 2025 and $153.6 million for Q1 2025.